Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Non-receptor tyrosine-protein kinase TYK2 is an enzyme encoded by the TYK2 gene. The Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) pipeline drugs market research report provides comprehensive information on the Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted therapeutics development with respective active and dormant or discontinued projects.
TYK2 Pipeline Drugs Market Segmentation by Therapy Areas
The key therapy areas of the TYK2 pipeline drugs market are immunology, gastrointestinal, dermatology, musculoskeletal disorders, oncology, central nervous system, infectious disease, respiratory, metabolic disorders, and ophthalmology. Immunology dominates the pipeline market.
TYK2 Pipeline Drugs Market Analysis, by Therapy Areas
For more TYK2 pipeline drugs market therapy areas insights, download a free report sample
TYK2 Pipeline Drugs Market Segmentation by Mechanisms of Action
The key mechanism of action of the TYK2 pipeline drugs market is Non Receptor Tyrosine Protein Kinase TYK2 Inhibitor.
TYK2 Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the TYK2 pipeline drugs market are oral, topical, ophthalmic, inhalational, and intravitreal. Most of the pipeline products are administered by the oral route.
TYK2 Pipeline Drugs Market Analysis, by Routes of Administration
For more TYK2 pipeline drugs market routes of administration insights, download a free report sample
TYK2 Pipeline Drugs Market Segmentation by Molecule Types
The key molecule type in the TYK2 pipeline drugs market is small molecule.
TYK2 Pipeline Drugs Market - Competitive Landscape
Some of the leading companies in the TYK2 pipeline drugs market are A2A Pharmaceuticals Inc, Alexion Pharmaceuticals Inc, Alumis Inc, Amgen Inc, Atomwise Inc, BeiGene Ltd, Bristol-Myers Squibb Co, Enitiate Biopharmaceuticals (Hangzhou) Co Ltd, Galapagos NV, and Haisco Pharmaceutical Group Co Ltd.
TYK2 Pipeline Drugs Market Analysis, by Companies
To know more about the companies in the TYK2 pipeline drugs market, download a free report sample
TYK2 Pipeline Drugs Market Report Overview
| Key Therapy Areas | Immunology, Gastrointestinal, Dermatology, Musculoskeletal Disorders, Oncology, Central Nervous System, Infectious Disease, Respiratory, Metabolic Disorders, and Ophthalmology |
| Key Mechanism of Action | Non Receptor Tyrosine Protein Kinase TYK2 Inhibitor |
| Key Routes of Administration | Oral, Topical, Ophthalmic, Inhalational, and Intravitreal |
| Key Molecule Type | Small Molecule |
| Leading Companies | A2A Pharmaceuticals Inc, Alexion Pharmaceuticals Inc, Alumis Inc, Amgen Inc, Atomwise Inc, BeiGene Ltd, Bristol-Myers Squibb Co, Enitiate Biopharmaceuticals (Hangzhou) Co Ltd, Galapagos NV, and Haisco Pharmaceutical Group Co Ltd |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2).
- Reviews of Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which includes product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key players involved in Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted therapeutics and enlists all their major and minor projects.
- Assessment of Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted therapeutics based on MoA, RoA, and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted therapeutics.
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Identify and understand the targeted therapy areas and indications for Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2). Identify the use of drugs for target identification and drug repurposing.
- Identify potential new clients or partners in the target demographic.
- Develop strategic initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics.
- Devise corrective measures for pipeline projects by understanding Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) development landscape.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Alexion Pharmaceuticals Inc
Alumis Inc
Amgen Inc
Atomwise Inc
BeiGene Ltd
Bristol-Myers Squibb Co
Galapagos NV
Haisco Pharmaceutical Group Co Ltd
InnoCare Pharma Ltd
Kinaset Therapeutics Inc
Merck & Co Inc
Neuron23 Inc
Nimbus Therapeutics LLC
Oncostellae SL
Pfizer Inc
Priovant Therapeutics Inc
Sareum Holdings Plc
Shenzhen Chipscreen Biosciences Co Ltd
Simcere Pharmaceutical Group Ltd
Sudo Biosciences Inc
Technoderma Medicines Inc
Theravance Biopharma Inc
TLL Pharmaceutical LLC
Ventyx Biosciences Inc
Xilingyuan Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas of the TYK2 pipeline drugs market?
The key therapy areas of the TYK2 pipeline drugs market are immunology, gastrointestinal, dermatology, musculoskeletal disorders, oncology, central nervous system, infectious disease, respiratory, metabolic disorders, and ophthalmology.
-
What are the key mechanisms of action of the TYK2 pipeline drugs market?
The key mechanism of action of the TYK2 pipeline drugs market is Non Receptor Tyrosine Protein Kinase TYK2 Inhibitor.
-
What are the key routes of administration in the TYK2 pipeline drugs market?
The key routes of administration in the TYK2 pipeline drugs market are oral, topical, ophthalmic, inhalational, and intravitreal.
-
What are the key molecule types in the TYK2 pipeline drugs market?
The key molecule type in the TYK2 pipeline drugs market is small molecule.
-
Which are the leading companies in the TYK2 pipeline drugs market?
Some of the leading companies in the TYK2 pipeline drugs market are A2A Pharmaceuticals Inc, Alexion Pharmaceuticals Inc, Alumis Inc, Amgen Inc, Atomwise Inc, BeiGene Ltd, Bristol-Myers Squibb Co, Enitiate Biopharmaceuticals (Hangzhou) Co Ltd, Galapagos NV, and Haisco Pharmaceutical Group Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Other Diseases reports